Myelin Breakdown and Iron Changes in Huntington’s Disease: Pathogenesis and Treatment Implications (original) (raw)
Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369–384 PubMedCAS Google Scholar
Li SH, Li XJ (2004) Huntingtin and its role in neuronal degeneration. Neuroscientist 10:467–475 ArticlePubMedCAS Google Scholar
Landles C, Bates GP (2004) Huntingtin and the molecular pathogenesis of Huntington’s disease. Fourth in molecular medicine review series. EMBO Rep 5:958–963 ArticlePubMedCAS Google Scholar
Harper PS, Shaw D (1996) Huntington’s disease: genetic and molecular studies. In: Harper PS (eds) Huntington’s disease 2nd edn. W.B.Saunders, Philadelphia, pp 241–293 Google Scholar
Persichetti F, Carlee L, Faber PW, McNeil SM, Ambrose CM, Srinidhi J, Anderson M, Barnes GT, Gusella JF, MacDonald ME (1996) Differential expression of normal and mutant Huntington’s disease gene alleles. Neurobiol Dis 3:183–190 ArticlePubMedCAS Google Scholar
Bartzokis G, Cummings J, Perlman S, Hance DB, Mintz J (1999) Increased basal ganglia iron levels in Huntington disease. Arch Neurol 56:569–574 ArticlePubMedCAS Google Scholar
Bartzokis G, Lu PH, Tishler TA, Perlman S (2006) In vivo assessment of iron in Huntington’s disease and other age-related degenerative brain diseases. In: Sigel A, Sigel H, Sigel RKO (eds) Metal ions in life sciences, vol 1. Wiley, Chichester, pp 151–177 Google Scholar
Jones AL (1996) The Huntington’s disease gene and its protein product. In: Harper PS (eds) Huntington’s disease, 2 edn. W.B.Saunders, Philadelphia, pp 293–316 Google Scholar
Mascalchi M, Lolli F, Della Nave R, Tessa C, Petralli R, Gavazzi C, Politi LS, Macucci M, Filippi M, Piacentini S (2004) Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain. Radiology 232:867–873 ArticlePubMed Google Scholar
Jernigan TL, Salmon DP, Butters N, Hesselink JR (1991) Cerebral structure on MRI, Part II: specific changes in Alzheimer’s and Huntington’s diseases. Biol Psychiatry 29:68–81 ArticlePubMedCAS Google Scholar
Aylward EH, Anderson NB, Bylsma FW, Wagster MV, Barta PE, Sherr M, Feeney J, Davis A, Rosenblatt A, Pearlson GD, Ross CA (1998) Frontal lobe volume in patients with Huntington’s disease. Neurology. 50:252–258 ArticlePubMedCAS Google Scholar
Mann DM, Oliver R, Snowden JS (1993) The topographic distribution of brain atrophy in Huntington’s disease and progressive supranuclear palsy. Acta Neuropathol (Berl) 85:553–559 CAS Google Scholar
Rosas HD, Koroshetz WJ, Chen YI, Skeuse C, Vangel M, Cudkowicz ME, Caplan K, Marek K, Seidman LJ, Makris N, Jenkins BG, Goldstein JM (2003) Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis. Neurology 60:1615–1620 PubMedCAS Google Scholar
Thieben MJ, Duggins AJ, Good CD, Gomes L, Mahant N, Richards F, McCusker E, Frackowiak RS (2002) The distribution of structural neuropathology in pre-clinical Huntington’s disease. Brain 125:1815–1828 ArticlePubMedCAS Google Scholar
Fennema-Notestine C, Archibald SL, Jacobson MW, Corey-Bloom J, Paulsen JS, Peavy GM, Gamst AC, Hamilton JM, Salmon DP, Jernigan TL (2004) In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Neurology 63:989–995 PubMedCAS Google Scholar
Paulsen JS, Magnotta VA, Mikos AE, Paulson HL, Penziner E, Andreasen NC, Nopoulos PC (2006) Brain structure in preclinical Huntington’s disease. Biol Psychiatry 59:57–63 ArticlePubMedCAS Google Scholar
Reading SA, Yassa MA, Bakker A, Dziorny AC, Gourley LM, Yallapragada V, Rosenblatt A, Margolis RL, Aylward EH, Brandt J, Mori S, van Zijl P, Bassett SS, Ross CA (2005) Regional white matter change in pre-symptomatic Huntington’s disease: a diffusion tensor imaging study. Psychiatry Res 140:55–62 ArticlePubMed Google Scholar
Bruyn GW (1973) Neuropathological changes in Huntington’s chorea. In: Barbeau A, Chase TN, Paulson GW (eds) Huntington’s Chorea, vol 1. Raven Press, New York, pp 399–403 Google Scholar
Liss L, Paulson GW, Sommer A (1973) Rigid form of Huntington’s chorea: a clinicopathological study of three cases. In: Barbeau A, Chase TN, Paulson GW (eds) Huntington’s Chorea, vol 1. Raven Press, New York, pp 405–424 Google Scholar
Klintworth GK (1973) Huntington’s chorea—morphologic contributions of a century. In: Barbeau A, Paulson GW, Chase TN (eds) Advances in neurology. Huntington’s chorea, vol 1. 1872–1972. Raven Press, New York, pp 353–368 Google Scholar
de la Monte SM, Vonsattel JP, Richardson EP Jr (1988) Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington’s disease. J Neuropathol Exp Neurol 47:516–525 Google Scholar
Peters A, Sethares C (2004) Oligodendrocytes, their progenitors and other neuroglial cells in the aging primate cerebral cortex. Cereb Cortex 14:995–1007 ArticlePubMed Google Scholar
Sotrel A, Paskevich PA, Kiely DK, Bird ED, Williams RS, Myers RH (1991) Morphometric analysis of the prefrontal cortex in Huntington’s disease. Neurology 41:1117–1123 PubMedCAS Google Scholar
Myers RH, Vonsattel JP, Paskevich PA, Kiely DK, Stevens TJ, Cupples LA, Richardson EP Jr, Bird ED (1991) Decreased neuronal and increased oligodendroglial densities in Huntington’s disease caudate nucleus. J Neuropathol Exp Neurol 50:729–742 PubMedCAS Google Scholar
Gomez-Tortosa E, MacDonald ME, Friend JC, Taylor SA, Weiler LJ, Cupples LA, Srinidhi J, Gusella JF, Bird ED, Vonsattel JP, Myers RH (2001) Quantitative neuropathological changes in presymptomatic Huntington’s disease. Ann Neurol 49:29–34 ArticlePubMedCAS Google Scholar
Bartzokis G (2004) Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease. Neurobiol Aging 25:5–18 ArticlePubMedCAS Google Scholar
Dexter DT, Jenner P, Schapira AH, Marsden CD (1992) Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson’s Disease Research Group. Ann Neurol 32(Suppl 1): S94–S100 ArticlePubMedCAS Google Scholar
Chen JC, Hardy PA, Kucharczyk W, Clauberg M, Joshi JG, Vourlas A, Dhar M, Henkelman RM (1993) MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. AJNR Am J Neuroradiol 14:275–281 PubMedCAS Google Scholar
Youdim MB, Ben-Shachar D, Riederer P (1991) Iron in brain function and dysfunction with emphasis on Parkinson’s disease. Eur Neurol 31(Suppl 1):34–40 PubMed Google Scholar
Connor JR, Benkovic SA (1992) Iron regulation in the brain: histochemical, biochemical, and molecular considerations. Ann Neurol 32(Suppl 1):S51–S61 ArticlePubMedCAS Google Scholar
Connor JR, Menzies SL (1995) Cellular management of iron in the brain. J Neurol Sci 134(Suppl):33–44 ArticlePubMedCAS Google Scholar
Bartzokis G, Tishler TA, Shin I-S, Lu PH, Cummings JL (2004) Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. In: LeVine S, Connor J, Schipper H (eds) Redox-active metals in neurological disorders, vol 1012. Ann N Y Acad Sci, New York, pp 224–236
Berg D, Youdim MB (2006) Role of iron in neurodegenerative disorders. Top Magn Reson Imaging 17:5–17 ArticlePubMed Google Scholar
Oldendorf WH, Oldendorf W Jr (1988) Basics of magnetic resonance imaging. Martinus Nijhof Publishing, Boston, MA Google Scholar
Kamman RL, Go KG, Brouwer W, Berendsen HJ (1988) Nuclear magnetic resonance relaxation in experimental brain edema: effects of water concentration, protein concentration, and temperature. Magn Reson Med 6:265–274 ArticlePubMedCAS Google Scholar
Bartzokis G, Aravagiri M, Oldendorf WH, Mintz J, Marder SR (1993) Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores. Magn Reson Med 29:459–464 ArticlePubMedCAS Google Scholar
Bartzokis G, Mintz J, Sultzer D, Marx P, Herzberg JS, Phelan CK, Marder SR (1994) In vivo MR evaluation of age-related increases in brain iron. AJNR Am J Neuroradiol 15:1129–1138 PubMedCAS Google Scholar
Vymazal J, Hajek M, Patronas N, Giedd JN, Bulte JW, Baumgarner C, Tran V, Brooks RA (1995) The quantitative relation between T1-weighted and T2-weighted MRI of normal gray matter and iron concentration. J Magn Reson Imaging 5:554–560 ArticlePubMedCAS Google Scholar
Vymazal J, Brooks RA, Patronas N, Hajek M, Bulte JW, Di Chiro G (1995) Magnetic resonance imaging of brain iron in health and disease. J Neurol Sci 134(Suppl 1):19–26 ArticlePubMedCAS Google Scholar
Peters A, Rosene DL, Moss MB, Kemper TL, Abraham CR, Tigges J, Albert MS (1996) Neurobiological bases of age-related cognitive decline in the rhesus monkey. J Neuropathol Exp Neurol 55:861–874 PubMedCAS Google Scholar
Bartzokis G, Sultzer D, Lu PH, Nuechterlein KH, Mintz J, Cummings J (2004) Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical “disconnection” in aging and Alzheimer’s disease. Neurobiol Aging 25:843–851 ArticlePubMedCAS Google Scholar
Bartzokis G, Lu PH, Geschwind DH, Edwards N, Mintz J, Cummings JL (2006) Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia. Arch Gen Psychiatry 63:63–72 ArticlePubMedCAS Google Scholar
Bartzokis G, Beckson M, Hance DB, Marx P, Foster JA, Marder SR (1997) MR evaluation of age-related increase of brain iron in young adult and older normal males. Magn Reson Imaging 15:29–35 ArticlePubMedCAS Google Scholar
Bartzokis G, Sultzer D, Mintz J, Holt LE, Marx P, Phelan CK, Marder SR (1994) In vivo evaluation of brain iron in Alzheimer’s disease and normal subjects using MRI. Biol Psychiatry 35:480–487 ArticlePubMedCAS Google Scholar
Vymazal J, Brooks RA, Baumgarner C, Tran V, Katz D, Bulte JW, Bauminger R, Di Chiro G (1996) The relation between brain iron and NMR relaxation times: an in vitro study. Magn Reson Med 35:56–61 ArticlePubMedCAS Google Scholar
Vymazal J, Zak O, Bulte JW, Aisen P, Brooks RA (1996) T1 and T2 of ferritin solutions: effect of loading factor. Magn Reson Med 36:61–65 ArticlePubMedCAS Google Scholar
Floyd RA, Carney JM (1993) The role of metal ions in oxidative processes and aging. Toxicol Ind Health 9:197–214 PubMedCAS Google Scholar
Morris CM, Candy JM, Oakley AE, Bloxham CA, Edwardson JA (1992) Histochemical distribution of non-haem iron in the human brain. Acta Anat (Basel) 144:235–257 CAS Google Scholar
Bartzokis G, Sultzer D, Cummings BJ, Holt LE, Hance DB, Henderson VW, Mintz J (2000) In vivo evaluation of brain iron in Alzheimer’s disease and normal controls using magnetic resonance imaging. Arch Gen Psychiatry 57:47–53 ArticlePubMedCAS Google Scholar
Bartzokis G, Tishler TA, Lu PH, Villablanca P, Altshuler LL, Carter M, Huang D, Edwards N, Mintz J (2007) Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging 28:414–423 ArticlePubMedCAS Google Scholar
Bulte JW, Miller GF, Vymazal J, Brooks RA, Frank JA (1997) Hepatic hemosiderosis in non-human primates: quantification of liver iron using different field strengths. Magn Reson Med 37:530–536 ArticlePubMedCAS Google Scholar
Bartzokis G, Cummings JL, Markham CH, Marmarelis PZ, Treciokas LJ, Tishler TA, Marder SR, Mintz J (1999) MRI evaluation of brain iron in earlier- and later-onset Parkinson’s disease and normal subjects. Magn Reson Imaging 17:213–222 ArticlePubMedCAS Google Scholar
Doraiswamy PM, Finefrock AE (2004) Metals in our minds: therapeutic implications for neurodegenerative disorders. Lancet Neurol 3:431–434 ArticlePubMedCAS Google Scholar
Ke Y, Ming Qian Z (2003) Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol 2:246–253 ArticlePubMedCAS Google Scholar
Lamantia AS, Rakic P (1990) Cytological and quantitative characteristics of four cerebral commissures in the rhesus monkey. J Comp Neurol 291:520–537 ArticlePubMedCAS Google Scholar
Kemper T (1994) Neuroanatomical and neuropathological changes during aging and dementia. In: Albert M, Knoefel J (eds) Clinical neurology of aging 2nd edn. Oxford University Press, New York, pp 3–67 Google Scholar
Yakovlev PI, Lecours AR (1967) Regional development of the brain in early life. Blackwell Scientific Publications, Boston, pp 3–70 Google Scholar
Hallgren B, Sourander P (1958) The effect of age on the non-haemin iron in the human brain. J Neurochem 3:41–51 ArticlePubMedCAS Google Scholar
Hotelling H (1940) The selection of variates for use in prediction with some comments on the general problem of nuisance parameters. Ann Math Stat 11:271–283 Google Scholar
Steiger JH (1980) Tests for comparing elements of a correlation matrix. Psychol Bull 87:245–251 Article Google Scholar
Hartman BK, Agrawal HC, Agrawal D, Kalmbach S (1982) Development and maturation of central nervous system myelin: comparison of immunohistochemical localization of proteolipid protein and basic protein in myelin and oligodendrocytes. Proc Natl Acad Sci USA 79:4217–4220 ArticlePubMedCAS Google Scholar
Trotter JL, Wegescheide CL, Garvey WF (1984) Regional studies of myelin proteins in human brain and spinal cord. Neurochem Res 9:133–146 ArticlePubMedCAS Google Scholar
Schwob VS, Clark HB, Agrawal D, Agrawal HC (1985) Electron microscopic immunocytochemical localization of myelin proteolipid protein and myelin basic protein to oligodendrocytes in rat brain during myelination. J Neurochem 45:559–571 ArticlePubMedCAS Google Scholar
Tolwani RJ, Cosgaya JM, Varma S, Jacob R, Kuo LE, Shooter EM (2004) BDNF overexpression produces a long-term increase in myelin formation in the peripheral nervous system. J Neurosci Res 77:662–669 ArticlePubMedCAS Google Scholar
Du Y, Fischer TZ, Lee LN, Lercher LD, Dreyfus CF (2003) Regionally specific effects of BDNF on oligodendrocytes. Dev Neurosci 25:116–126 ArticlePubMedCAS Google Scholar
Djalali S, Holtje M, Grosse G, Rothe T, Stroh T, Grosse J, Deng DR, Hellweg R, Grantyn R, Hortnagl H, Ahnert-Hilger G (2005) Effects of brain-derived neurotrophic factor (BDNF) on glial cells and serotonergic neurones during development. J Neurochem 92:616–627 ArticlePubMedCAS Google Scholar
Gauthier LR, Charrin BC, Borrell-Pages M, Dompierre JP, Rangone H, Cordelieres FP, De Mey J, MacDonald ME, Lessmann V, Humbert S, Saudou F (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118:127–138 ArticlePubMedCAS Google Scholar
Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Martin-Ibanez R, Munoz MT, Mengod G, Ernfors P, Alberch J (2004) Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington’s disease. J Neurosci 24:7727–7739 ArticlePubMedCAS Google Scholar
O’Kusky J, Colonnier M (1982) Postnatal changes in the number of astrocytes, oligodendrocytes, and microglia in the visual cortex (area 17) of the macaque monkey: a stereological analysis in normal and monocularly deprived animals. J Comp Neurol 210:307–315 ArticlePubMedCAS Google Scholar
Bartzokis G (2004) Quadratic trajectories of brain myelin content: unifying construct for neuropsychiatric disorders. Neurobiol Aging 25:49–62 ArticleCAS Google Scholar
LeVine SM, Macklin WB (1990) Iron-enriched oligodendrocytes: a reexamination of their spatial distribution. J Neurosci Res 26:508–512 ArticlePubMedCAS Google Scholar
Quintana C, Bellefqih S, Laval JY, Guerquin-Kern JL, Wu TD, Avila J, Ferrer I, Arranz R, Patino C (2006) Study of the localization of iron, ferritin, and hemosiderin in Alzheimer’s disease hippocampus by analytical microscopy at the subcellular level. J Struct Biol 153:42–54 ArticlePubMedCAS Google Scholar
Dwork AJ (1995) Effects of diet and development upon the uptake and distribution of cerebral iron. J Neurol Sci 134(Suppl 1):45–51 ArticlePubMedCAS Google Scholar
Connor JR, Menzies SL (1996) Relationship of iron to oligodendrocytes and myelination. Glia 17:83–93 ArticlePubMedCAS Google Scholar
Erb GL, Osterbur DL, LeVine SM (1996) The distribution of iron in the brain: a phylogenetic analysis using iron histochemistry. Brain Res Dev Brain Res 93:120–128 ArticlePubMedCAS Google Scholar
Hill JM, Switzer RC (1984) The regional distribution and cellular localization of iron in the rat brain. Neuroscience 11:595–603 ArticlePubMedCAS Google Scholar
Sapp E, Kegel KB, Aronin N, Hashikawa T, Uchiyama Y, Tohyama K, Bhide PG, Vonsattel JP, DiFiglia M (2001) Early and progressive accumulation of reactive microglia in the Huntington disease brain. J Neuropathol Exp Neurol 60:161–172 PubMedCAS Google Scholar
Pavese N, Gerhard A, Tai YF, Ho AK, Turkheimer F, Barker RA, Brooks DJ, Piccini P (2006) Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology 66:1638–1643 ArticlePubMedCAS Google Scholar
Mehlhase J, Gieche J, Widmer R, Grune T (2006) Ferritin levels in microglia depend upon activation: modulation by reactive oxygen species. Biochim Biophys Acta 1763:854–859 ArticlePubMedCAS Google Scholar
Zhang X, Surguladze N, Slagle-Webb B, Cozzi A, Connor JR (2006) Cellular iron status influences the functional relationship between microglia and oligodendrocytes. Glia 54:795–804 ArticlePubMedCAS Google Scholar
O’Kusky J, Colonnier M (1982) A laminar analysis of the number of neurons, glia, and synapses in the visual cortex (area 17) of adult macaque monkeys. J Comp Neurol 210:278–290 ArticlePubMedCAS Google Scholar
Bartzokis G, Beckson M, Lu PH, Nuechterlein KH, Edwards N, Mintz J (2001) Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. Arch Gen Psychiatry 58:461–465 ArticlePubMedCAS Google Scholar
Bartzokis G (2002) Schizophrenia: breakdown in the well-regulated lifelong process of brain development and maturation. Neuropsychopharmacology 27:672–683 ArticlePubMed Google Scholar
Bartzokis G (2005) Brain myelination in prevalent neuropsychiatric developmental disorders: primary and comorbid addiction. Adolesc Psychiatry 29:55–96 Google Scholar
Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington’s disease. J Neuropathol Exp Neurol 44:559–577 PubMedCAS Google Scholar
Crapper McLachlan DR, Dalton AJ, Kruck TP, Bell MY, Smith WL, Kalow W, Andrews DF (1991) Intramuscular desferrioxamine in patients with Alzheimer’s disease [published erratum appears in Lancet 1991 Jun 29;337(8757):1618] [see comments]. Lancet 337:1304–1308 ArticlePubMedCAS Google Scholar
Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, Kiers L, Cherny R, Li QX, Tammer A, Carrington D, Mavros C, Volitakis I, Xilinas M, Ames D, Davis S, Beyreuther K, Tanzi RE, Masters CL (2003) Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol 60:1685–1691 ArticlePubMed Google Scholar
Shin RW, Kruck TP, Murayama H, Kitamoto T (2003) A novel trivalent cation chelator feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer’s disease. Brain Res 961:139–146 ArticlePubMedCAS Google Scholar
Kaur D, Yantiri F, Rajagopalan S, Kumar J, Mo JQ, Boonplueang R, Viswanath V, Jacobs R, Yang L, Beal MF, DiMonte D, Volitaskis I, Ellerby L, Cherny RA, Bush AI, Andersen JK (2003) Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson’s disease. Neuron 37:899–909 ArticlePubMedCAS Google Scholar
Nguyen T, Hamby A, Massa SM (2005) Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington’s disease mouse model. Proc Natl Acad Sci USA 102:11840–11845 ArticlePubMedCAS Google Scholar
Newman MB, Arendash GW, Shytle RD, Bickford PC, Tighe T, Sanberg PR (2002) Nicotine’s oxidative and antioxidant properties in CNS. Life Sci 71:2807–2820 ArticlePubMedCAS Google Scholar
Finefrock AE, Bush AI, Doraiswamy PM (2003) Current status of metals as therapeutic targets in Alzheimer’s disease. J Am Geriatr Soc 51:1143–1148 ArticlePubMed Google Scholar
Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, Chang J, Thill GLevesque M, Zhang M, Hession C, Sah D, Trapp B, He Z, Jung V, McCoy JM, Pepinsky RB (2005) LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci 8:745–751 ArticlePubMedCAS Google Scholar
Youdim MB, Stephenson G, Ben Shachar D (2004) Ironing iron out in Parkinson’s disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28. Ann NY Acad Sci 1012:306–325 ArticlePubMedCAS Google Scholar
Bartzokis G, Lu PH, Mintz J (2004) Quantifying age-related myelin breakdown with MRI: novel therapeutic targets for preventing cognitive decline and Alzheimer’s disease. J Alzheimers Dis 6:S53–S59 PubMedCAS Google Scholar